Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II

By Staatz Christine E.   Goodman Lucy K.   Tett Susan E.  

Clinical Pharmacokinetics, Vol. 49, Iss. 4, 2010-04 ,pp. : 207-221

Adis International

Access to resources Recommend Favorite

Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam

By Drabant Sándor   Tóth Mária   Bereczki Andrea   Bajnógel Judit   Tömlö Judit   Klebovich Imre  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 7, 2006-07 ,pp. : 587-588

Springer Publishing Company

Access to resources Recommend Favorite

Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping tests

By Lee Su-Jun   Goldstein Joyce A  

Pharmacogenomics, Vol. 6, Iss. 4, 2005-06 ,pp. : 357-371

Future Medicine

Access to resources Recommend Favorite

CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation

By Capron Arnaud   Mourad Michel   De Meyer Martine   De Pauw Luc   Eddour Djamila Chaib   Latinne Dominique   Elens Laure   Haufroid Vincent   Wallemacq Pierre  

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 703-714

Future Medicine

Access to resources Recommend Favorite

Frequencies of Single Nucleotide Polymorphisms in Cytochrome P450 Genes (CYP1A2, 2A6, 2B6, 3A4 and 3A5) in a Rwandan Population: Difference to Other African Populations

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 3, 2013-09 ,pp. : 237-246

Bentham Science Publishers

Access to resources Recommend Favorite